Symbol="EXEL"
AssetType="Common Stock"
Name="Exelixis Inc"
Description="Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California."
CIK="939767"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="7007708000"
EBITDA="165719000"
PERatio="45.79"
PEGRatio="0.316"
BookValue="7.89"
DividendPerShare="0"
DividendYield="0"
EPS="0.47"
RevenuePerShareTTM="5.3"
ProfitMargin="0.0958"
OperatingMarginTTM="0.0824"
ReturnOnAssetsTTM="0.0293"
ReturnOnEquityTTM="0.0668"
RevenueTTM="1714291000"
GrossProfitTTM="1553153000"
DilutedEPSTTM="0.47"
QuarterlyEarningsGrowthYOY="0.136"
QuarterlyRevenueGrowthYOY="0.12"
AnalystTargetPrice="24.5"
TrailingPE="45.79"
ForwardPE="10.58"
PriceToSalesRatioTTM="3.111"
PriceToBookRatio="2.042"
EVToRevenue="2.258"
EVToEBITDA="9.66"
Beta="0.672"
num_52WeekHigh="21.76"
num_52WeekLow="14.87"
num_50DayMovingAverage="19.52"
num_200DayMovingAverage="18.08"
SharesOutstanding="325637000"
DividendDate="None"
ExDividendDate="None"
symbol="EXEL"
open="21.35"
high="21.42"
low="20.99"
price="21.00"
volume="1713368.00"
latest_trading_day="2023-08-17"
previous_close="21.32"
change="-0.32"
change_percent="-1.5009%"
aroon_positive_momentum_days="88"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="88"
Volume_recent_avg="2511942"
Change_recent_avg="0.02"
Delta_recent_avg="0.41"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="88"
Aroon_momentum_negative="12"
image_negative_thumbnail_id_1="147"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0029.jpeg"
image_negative_thumbnail_id_2="157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0019.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="656"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_positive_thumbnail_id_2="954"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
